Spokespeople for the companies declined to comment on the report but acknowledged their interest in that segment of the cannabis market.
Coca-Cola is one of the most recognized brands in the world, but it could soon be known for more than just fizzy drinks.
Last month, Corona beer brewer Constellation Brands Inc. announced it would spend $3.8 billion to increase its stake in Canopy Growth Corp., the Canadian marijuana producer with a value that exceeds C$13 billion ($10 billion).
"So there's a lot of focus on beverage alcohol, there's a huge huge market, but if you see the other infused drinks it could be a much bigger", Athaide said.
"The space is evolving quickly", spokesman Ken Landers told Bloomberg.
Coke could be well positioned to capture market share should CBD and other marijuana products become legal, said Bonnie Herzog, analyst with Wells Fargo.
Trump’s ex-campaign chairman reaches ‘cooperation’ deal with USA prosecutors - Ireland
In a statement, the White House distanced Trump from the veteran operative who helped get him elected against the odds in 2016. Fuelling speculation over Russia's role in the last presidential election is a June 9, 2016 meeting in Trump Tower in NY .
The drinks will be expected to ease inflammation, pain and cramping.
Coca-Cola is making some waves today with news that it's considering a new ingredient: cannabis.
The law makes Canada the second country to have a nationwide, legal marijuana market, after Uruguay.
The report said there was no guarantee that talks between the companies would be successful but Aurora shares responded by soaring 22 percent.
The world's largest beverage company may be the next industry giant to jump into the cannabis-drinks business.
'It's going to be more of the "recovery drink" category'.
So, with fizzy drinks are becoming increasingly unpopular (no thanks to our pal, Jamie Oliver), Bloomberg reports that the the worldwide franchise is looking to delve into the cannabis sector.
In June, America's medicines regulator approved Epidiolex, a British-made epilepsy treatment that contains cannabidiol.